InvestorsHub Logo
Followers 219
Posts 15977
Boards Moderated 7
Alias Born 06/02/2007

Re: Empiricst1 post# 389599

Wednesday, 05/04/2022 7:40:51 AM

Wednesday, May 04, 2022 7:40:51 AM

Post# of 403018
"The materials are from the Library of Congress site. The materials appearing on the site could have been used by IPIX any way they wanted to. The materials I showed were from the cites I mentioned."

I owe you an apology. The quote from the IPIX(CTIX) PR was quoted verbatim from a now deleted CTIX link (which was working as recently as a couple of years ago) which used to be found here:

http://files.shareholder.com/downloads/ABEA-4ITCYZ/1997024712x0x611205/FEA66C67-D02F-4FF2-B230-AA711F46ED7F/PMX-30063_Antibiotic_Fact_Sheet_Nov_2012_.pdf

So I'm sorry for disputing what you said. I was wrong.


But to be clear, this link is to an open access non-peer reviewed paper that happens to be published on an NIH site. It's authored by a consultant to the pharmaceutical industry who is paid to write such papers. It doesn't imply NIH or any other official body endorsement of brilacidin or the results IPIX claim it has obtained.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854692/#bib-013

“The saddest lessons of history is this: If we’ve been conned long enough, we reject any evidence of the con. It’s too painful to acknowledge, even to ourselves, that we’ve been taken. if you give a charlatan power over you, you never get it back.”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News